GuardRX
Non-profit research and development organization (founded 2018) focused on low-cost vaccine and diagnostic development for emerging and neglected infectious diseases, mobile molecular diagnostics and field-deployable laboratory solutions, and strengthening laboratory and surveillance capacity in resource-limited settings. Operates a laboratory certified for Biosafety Level 2 work and conducts field training and mobile laboratory deployments, with an emphasis on vaccine platforms, serology, and assay validation.
Industries
GuardRX
Products
Low-cost vaccine candidates for emerging and neglected diseases
Vaccine candidates developed for emerging and neglected pathogens, intended for cost-effective production and deployment.
Cost-effective diagnostic kits and serological tests
ELISA-based serological assays and other diagnostic reagents designed for surveillance and clinical use in resource-limited settings.
Veterinary vaccines targeting vector-borne zoonoses
Vaccine candidates intended to reduce transmission of zoonotic pathogens by targeting animal reservoirs and vectors.
Low-cost vaccine candidates for emerging and neglected diseases
Vaccine candidates developed for emerging and neglected pathogens, intended for cost-effective production and deployment.
Cost-effective diagnostic kits and serological tests
ELISA-based serological assays and other diagnostic reagents designed for surveillance and clinical use in resource-limited settings.
Veterinary vaccines targeting vector-borne zoonoses
Vaccine candidates intended to reduce transmission of zoonotic pathogens by targeting animal reservoirs and vectors.
Services
Mobile molecular diagnostic services
On-site molecular diagnostic testing delivered via fully equipped mobile laboratories for outbreak response and travel screening.
Field training and laboratory capacity building
Training programs and technical support to build local laboratory diagnostic and clinical trial capacities, including good laboratory practices and data generation standards.
Assay development and validation services
Development and validation of serological assays (ELISA), pseudovirus neutralization tests, and monoclonal antibody functional assays to support preclinical and clinical studies.
Vaccine and diagnostic development partnerships
Collaborative development and production of low-cost vaccines and diagnostic kits tailored to emerging and neglected diseases.
Mobile molecular diagnostic services
On-site molecular diagnostic testing delivered via fully equipped mobile laboratories for outbreak response and travel screening.
Field training and laboratory capacity building
Training programs and technical support to build local laboratory diagnostic and clinical trial capacities, including good laboratory practices and data generation standards.
Assay development and validation services
Development and validation of serological assays (ELISA), pseudovirus neutralization tests, and monoclonal antibody functional assays to support preclinical and clinical studies.
Vaccine and diagnostic development partnerships
Collaborative development and production of low-cost vaccines and diagnostic kits tailored to emerging and neglected diseases.
Expertise Areas
- Vaccine development
- Diagnostic assay development
- Clinical trial management and implementation
- Laboratory capacity strengthening and field training
Key Technologies
- Field-deployable molecular diagnostics
- Mobile laboratory platforms
- Recombinant protein expression systems
- Cell culture